Suppr超能文献

深入了解调控精原干细胞增殖与分化的机制

Insights into the Regulation on Proliferation and Differentiation of Stem Leydig Cells.

机构信息

Department of Infertility and Sexual Medicine, The Third Affiliated Hospital, Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, China.

出版信息

Stem Cell Rev Rep. 2021 Oct;17(5):1521-1533. doi: 10.1007/s12015-021-10133-x. Epub 2021 Feb 17.

Abstract

Male hypogonadism is a clinical syndrome caused by testosterone deficiency. Hypogonadism can be caused by testicular disease (primary hypogonadism) or hypothalamic-pituitary dysfunction (secondary hypogonadism). The present strategy for treating hypogonadism is the administration of exogenous testosterone. But exogenous testosterone is reported to have negative side effects including adverse cardiovascular events and disruption of physiological spermatogenesis probably due to its inability to mimic the physiological circadian rhythm of testosterone secretion in vivo. In recent years, a growing number of articles demonstrated that stem Leydig cells (SLCs) can not only differentiate into functional Leydig cells (LCs) in vivo to replace chemically disrupted LCs, but also secrete testosterone in a physiological pattern. The proliferation and differentiation of SLCs are regulated by various factors. However, the mechanisms involved in regulating the development of SLCs remain to be summarized. Factors involved in the regulation of SLCs can be divided into environmental pollutants, growth factors, cytokine and hormones. Environmental pollutants such as Perfluorooctanoic acid (PFOA) and Triphenyltin (TPT) could suppress SLCs proliferation or differentiation. Growth factors including FGF1, FGF16, NGF and activin A are essential for the maintenance of SLCs self-renewal and differentiation. Interleukin 6 family could inhibit differentiation of SLCs. Among hormones, dexamethasone suppresses SLCs differentiation, while aldosterone suppresses their proliferation. The present review focuses on new progress about factors regulating SLC's proliferation and differentiation which will undoubtedly deepen our insights into SLCs and help make better clinical use of them. Different factors affect on the proliferation and differentiation of stem Leydig cells. Firstly, each rat was intraperitoneally injected EDS so as to deplete Leydig cells from the adult testis. Secondly, the CD51+ or CD90+ cells from the testis of rats are SLCs, and the p75+ cells from human adult testes are human SLCs. These SLCs in the testis start to proliferate and some of them differentiate into LCs. Thirdly, during the SLCs regeneration period, researchers could explore different function of those factors (pollutants, growth factors, cytokines and hormones) towards SLCs.

摘要

男性性腺功能减退症是由睾酮缺乏引起的临床综合征。性腺功能减退症可由睾丸疾病(原发性性腺功能减退症)或下丘脑-垂体功能障碍(继发性性腺功能减退症)引起。目前治疗性腺功能减退症的策略是外源性睾酮的应用。但是,外源性睾酮据报道具有负面的副作用,包括不良心血管事件和对生理生精的破坏,这可能是由于其无法模拟体内睾酮分泌的生理昼夜节律。近年来,越来越多的文章表明,干细胞莱迪希细胞(SLCs)不仅可以在体内分化为功能性莱迪希细胞(LCs)来替代化学破坏的 LCs,而且可以以生理模式分泌睾酮。SLCs 的增殖和分化受多种因素的调节。然而,调节 SLCs 发育的机制仍有待总结。SLCs 调节因素可分为环境污染物、生长因子、细胞因子和激素。全氟辛酸(PFOA)和三苯基锡(TPT)等环境污染物可抑制 SLCs 的增殖或分化。包括 FGF1、FGF16、NGF 和激活素 A 在内的生长因子对于 SLCs 的自我更新和分化是必不可少的。白细胞介素 6 家族可以抑制 SLCs 的分化。在激素中,地塞米松抑制 SLCs 的分化,而醛固酮抑制其增殖。本综述重点介绍了调节 SLC 增殖和分化的新进展,这无疑将加深我们对 SLCs 的了解,并有助于更好地对其进行临床应用。不同的因素对干细胞莱迪希细胞的增殖和分化有影响。首先,每只大鼠都被腹腔注射 EDS,以使成年睾丸中的莱迪希细胞耗竭。其次,来自大鼠睾丸的 CD51+或 CD90+细胞是 SLCs,来自人成年睾丸的 p75+细胞是人 SLCs。这些睾丸中的 SLCs 开始增殖,其中一些分化为 LCs。第三,在 SLCs 再生期间,研究人员可以探索这些因素(污染物、生长因子、细胞因子和激素)对 SLCs 的不同功能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验